Rosuvastatin may reduce risk of all-cause mortality and major adverse cardiovascular events compared with atorvastatin
1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality and major adverse cardiovascular events compared with atorvastatin. 2. Initiation of rosuvastatin and atorvastatin...